Chronic Kidney Disease

Chronic kidney disease (CKD) is a health condition that involves reduced function of the kidneys. There are various causes of reduced kidney function and the severity of the condition can vary greatly.

Chronic Kidney Disease (CKD)

Chronic kidney disease is a health condition that involves the reduced function of the kidneys.

Living with Chronic Kidney Disease

Chronic Kidney Disease Symptoms

Chronic Kidney Disease Causes

Chronic Kidney Disease Diagnosis

Chronic Kidney Disease Treatment

Chronic Kidney Disease Prevention

Chronic Kidney Disease Patients and Exercise

Importance of Early Detection for Kidney Disease

Investigating the Epidemic for Chronic Kidney Disease

Risk Factors for Chronic Kidney Disease

Latest Chronic Kidney Disease News and Research

Study reveals long-term consequences of atrial fibrillation

The lifetime risk of atrial fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) has increased from one in four to one in three over the past two decades, finds a study from Denmark in The BMJ today.

17 Apr 2024

Lifetime risk of atrial fibrillation rises to nearly 31% in recent decade

The risk of both AF and its complications in a Danish national cohort, beginning from the age of 45 years.

17 Apr 2024

Kidney-CHAMP framework provides equitable access and overcomes barriers to kidney disease care

Manisha Jhamb, M.D., launched the Kidney-CHAMP study five years ago because she saw a looming tsunami of chronic kidney disease cases. She was pulled to find a way to assist the primary care physicians upon whom this burden would fall.

16 Apr 2024

High blood levels of TMAO predicts chronic kidney disease risk in future

New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time.

9 Apr 2024

Researchers find new clues to understanding the progression of primary membranous nephropathy

No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood.

9 Apr 2024

SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths

study reveals that SGLT2 inhibitors consistently lower the risk of major adverse cardiovascular events by 9% across various patient groups, especially impacting cardiovascular death reduction, highlighting their broad therapeutic potential beyond diabetes management.

9 Apr 2024

Study: Empagliflozin shows mixed results in heart attack patients

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

COVID-19 shatters decades of global health progress, slashing life expectancy

Study in The Lancet reveals COVID-19 as the second leading cause of death in 2021, disrupting three decades of progress in global health and reducing life expectancy by 2.2 years from 2019 to 2021 despite previous gains.

7 Apr 2024

Study shows promise of zilebesiran injection in reducing systolic blood pressure

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at three months in patients whose blood pressure had remained uncontrolled despite compliance with their medication regimen, according to a study presented at the American College of Cardiology's Annual Scientific Session.

7 Apr 2024

Hot climates worsen chronic kidney disease outcomes

Chronic kidney disease patients living in the hottest countries experienced an additional 8% drop in kidney function each year compared to those living in temperate climates, finds a new study from researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM).

5 Apr 2024

Dietary choices are linked to higher rates of preeclampsia among Latinas

For pregnant Latinas, food choices could reduce the risk of preeclampsia, a dangerous type of high blood pressure, and a diet based on cultural food preferences, rather than on U.S. government benchmarks, is more likely to help ward off the illness, a new study shows.

5 Apr 2024

Genetic analysis reveals hidden causes of chronic kidney disease in adults

Chronic kidney disease (CKD) is extremely prevalent among adults, affecting over 800 million individuals worldwide.

3 Apr 2024

To ban or not to ban, the case for reformulating ultra-processed foods

Despite concerns about ultra-processed foods (UPFs) and non-communicable diseases (NCDs), evidence of causality remains unclear; reformulating UPFs may offer significant health advantages.

1 Apr 2024

Ultra-processed foods raise chronic kidney disease risk, study shows

Consuming ultra-processed foods is linked to an 18% increased risk of chronic kidney disease, with every 10% rise in UPF intake energy contributing to a 7% greater CKD risk.

1 Apr 2024

Childhood BMI tied to higher blood pressure in middle age

Children and teenagers living with overweight or obesity are more likely to have high blood pressure as adults (aged 50-64 years), suggesting the processes behind the condition could begin as early as childhood, suggests new research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May).

1 Apr 2024

Heavy drinkers who cut back see major heart health benefits, study finds

Study shows that heavy drinkers who reduced their alcohol intake experienced a significantly lower risk of major adverse cardiovascular events, underscoring the potential benefits of alcohol reduction on heart health.

31 Mar 2024

Research identifies optimal body weight to reduce cardiovascular risk in diabetes patients

New research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimize their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease.

30 Mar 2024

Benchmarking lifestyle medicine's effectiveness with new performance measures

An expert panel has published the first performance measures to identify remission and evaluate the effectiveness of lifestyle medicine treatments, which will allow more objective comparisons between lifestyle behavior interventions and other non-lifestyle treatments.

28 Mar 2024

How do acetylsalicylic acid and warfarin interact with various nutrients?

45 drug-nutrient interactions (DNIs) that modify micro-nutritional status, particularly focusing on how acetylsalicylic acid (ASA) and warfarin may affect patients through various mechanisms.

28 Mar 2024

Study: Environmental and social adversities double heart disease risk

People who live in areas with social and environmental adversities may have up to twice the increased risk for developing heart disease and stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

27 Mar 2024